<< Impact of the economic downturn on the pharmaceutical industry | Novo Nordisk initiates its share repurchase programme >>

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Published on October 5, 2009 at 8:29 AM · No Comments

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

Data from the following clinical trials of Caldolor will be displayed in poster presentations on Saturday, October 10, 2009, from 1:30-3:00 pm Mountain Time:

A phase III dose ranging pain study entitled "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen for the Management of Postoperative Pain in Adults" will be presented by principal author, Stephen R. Southworth, MD, FACS (study 008A, poster #49).
A phase III abdominal hysterectomy pain study entitled "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen for the Management of Postoperative Pain in Adults," authored by Peter Kroll, M.D., will be presented by co-author Laura Meadows, BC, CRCC (study 008B, poster #50).

In conjunction with the presentations, copies of the posters will be available on Cumberland's website at http://investor.shareholder.com/cpix/events.cfm, or by contacting the Company at 615-255-0068.

SOURCE: Cumberland Pharmaceuticals Inc.

cb4d05d5-7431-4cf3-8c19-86dfb9e1564a|0|.0

Posted in: Drug Trial News

Tags: Acetaminophen, Aspirin, Asthma, Blood Pressure, Gastroenterology, Heart Failure, Hospital, Hypersensitivity, Hysterectomy, Ibuprofen, Placebo, Ulcer, Urticaria

Related posts

Merck announces FDA approval for GARDASIL against HPV-related anal cancerMerck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Dru...
Scientists create functioning human intestinal tissue from pluripotent stem cellsFor the first time, scientists have created functioning human intestinal tissue in the laboratory fr...
Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndromeSeaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled stud...
Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDAAlkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the com...
Merit Medical Systems to acquire BioSphere MedicalMerit Medical Systems, Inc. today announced that it has signed a definitive merger agreement to acqu...
Survey shows alarming increase of peanut allergies in childrenResults of a nationwide telephone survey have shown that the rate of peanut allergies in children mo...
Interventions for enhancing medication adherencePatients often do not take the medicines their doctors prescribe, and a new review of existing resea...
Health survey reveals interesting facts about NSW residentsA population survey by the NSW Department of Health has revealed a number of interesting facts.
Avoid Chinese toothpaste!The U.S. Food and Drug Administration (FDA) today warned consumers to avoid using tubes of toothpast...
Caffeine can help reduce the post-workout sorenessAlthough it's too soon to recommend dropping by Starbucks before hitting the gym, a new study sugges...
Link between common lifestyle factors, immune system and cancerThe immune system is fickle, and easily influenced by more than just viruses and bacteria. It can be...
Sunshine Heart awarded $2.15m grant to support development of heart assist deviceSunshine Heart, Inc., today announced it has been awarded a second Commercial Ready Grant (CRG) from...
Fullerene shows promise in reducing radiation side effectsUsing transparent zebrafish embryos, researchers at Jefferson Medical College in Philadelphia have s...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.